Corporate Information And Statement Of Ifrs Compliance [Abstract]

Xspray Pharma - Filing #690674

Concept	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2021-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	Xspray	—	—
Domicile of entity	Solna	—	—
Legal form of entity	aktiebolag	—	—
Country of incorporation	svenskt	—	—
Address of entity's registered office	Råsundavägen 12, 169 67 Solna	—	—
Principal place of business		—	—
Description of nature of entity's operations and principal activities		—	—
Name of parent entity	Xspray Pharma AB	—	—
Statement of IFRS compliance [text block]		—	—
Disclosure of uncertainties of entity's ability to continue as going concern [text block]		—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	—	8 552 SEK	6 199 SEK
Current trade payables	—	14 786 SEK	16 865 SEK
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment		—	—